临床儿科杂志 ›› 2015, Vol. 33 ›› Issue (5): 426-.doi: 10.3969 j.issn.1000-3606.2015.05.007

• 血液肿瘤疾病专栏 • 上一篇    下一篇

急性白血病患儿血培养病原菌分布及耐药性分析

潘伟   

  1. 南京医科大学附属南京儿童医院检验科( 江苏南京 210008)
  • 收稿日期:2015-05-15 出版日期:2015-05-15 发布日期:2015-05-15
  • 通讯作者: 潘伟 E-mail:panwei303303@sina.com

Blood culture and analysis of drug resistance of pathogenic microbes in children with acute leukemia

PAN Wei   

  1. The Affiliated Children's Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu China
  • Received:2015-05-15 Online:2015-05-15 Published:2015-05-15

摘要: 目的 探讨急性白血病(AL)患儿血培养病原菌分布及其耐药特点。方法 采集AL患儿血标本进行培养,采用API或VITEK-2 Compact细菌鉴定系统进行细菌鉴定,K-B法检测抗菌药物敏感性。结果 6 400份AL患儿血标本培养阳性713例,阳性率为11.1%;在首次分离的655株菌株中,革兰阳性菌344株,占52.5%,以葡萄球菌为主,未发现耐万古霉素和利奈唑胺的葡萄球菌株;革兰阴性菌278株,占42.5%,以黏质沙雷菌和大肠埃希菌为主,对亚胺培南的敏感率达100%;真菌33株,占5.0%。结论 AL患儿血培养阳性菌以葡萄球菌、黏质沙雷菌和大肠埃希菌为主,药敏试验有助于临床选择合适的抗菌药物。

Abstract:  Objective To investigate the distribution of pathogenic microbes in blood culture and analysis of drug resistance of common pathogens in children with acute leukemia. Methods BACTE-FX system made by BD company was applied for the blood culture of children with acute leukemia. API or VITEK-2 Compact bacterial identification system was used for identification of bacteria. Antimicrobial susceptibility testing was performed by disk diffusion method. Results Among 6400 blood culture samples in children with acute leukemia, 713 cases were positive at the rate of 11.1%. Among 655 strains first isolated from the patient, Gram-positive bacteria were 52.5% (344/655) and dominated by Staphylococcus. Strains resistant to vancomycin and linezolid were not found. 278 strains (42.5%) were Gram-negative bacteria , and S.marcescens and E.coli were dominated. Gram-negetive bacteria showed high antibacterial activity to imipenem with the sensitive rate of 100%. 33 strains (5%) were fungi. Conclusions Staphylococcus, S.marcescens, and E.coli were the most important bacteria in blood culture of children with acute leukemia. We can offer effective help for clinical treatment with the susceptibility testing.